US
(888) 440-0954

Resources

Haplotype analysis detects MLH1 founder variant in Indian Lynch syndrome patient cohort.

Familial Cancer 24, 13 (2025), Dec 19, 2024

PMID: 39702679

Lynch syndrome (LS) is an autosomal dominant hereditary cancer predisposition syndrome whereby the lifetime risk of developing gastrointestinal and genitourinary cancers rises by to over 50%. It is caused by heterozygous variants in the DNA mismatch repair genes- MLH1, MSH2, MSH6 and PMS2, with the majority detected in MLH1 and MSH2. Recurrently observed LS-associated variants in apparently unrelated individuals have either arisen de novo in different families due to mutation hotspots or are inherited from a common ancestor (founder) that lived several generations back. Testing for founder variants can facilitate molecular diagnosis of LS more efficiently and cost effectively than screening for all possible variants in the MMR genes.

Read More

 

Considering Genomic Research?

    Fields marked in * is mandatory to fill
     
     
     

    2025 © MedGenome • All Rights Reserved
    Request a Quote